Evidence map›Paper›PMID 30608961›Full record

ArticlePloS one2019

Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein.

Menglan Chen, Steven G Carmella, Chistopher Sipe, Joni Jensen, Xianghua Luo, Chap T Le, Sharon E Murphy, Neal L Benowitz, F Joseph McClernon, Ryan Vandrey and 9 more

Open access · goldAbstract readValidation Study
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Urinary Cyanoethyl Mercapturic Acid, a Biomarker of the Smoke Toxicant Acrylonitrile, Clearly Distinguishes Smokers From Nonsmokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  2. Trial
  3. Trial
  4. Article
  5. Association of Urinary Biomarkers of Tobacco Exposure with Lung Cancer Risk in African American and White Cigarette Smokers in the Southern Community Cohort Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  6. Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  7. Article
  8. Article
  9. Optimal Cutoff Concentration of Urinary Cyanoethyl Mercapturic Acid for Differentiating Cigarette Smokers From Nonsmokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 1 country.

Menglan ChenMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Steven G CarmellaMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Chistopher SipeMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Joni JensenMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Xianghua LuoMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Chap T LeMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Sharon E MurphyMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Neal L BenowitzDepartment of Medicine, University of California, San Francisco, California, United States of America.
F Joseph McClernonDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina, United States of America.
Ryan VandreyDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, Maryland, United States of America.
Sharon S AllenDepartment of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.
Rachel Denlinger-ApteDepartment of Behavioral and Social Sciences, Brown University, Providence, Rhode Island, United States of America.
Paul M CinciripiniDepartment of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Andrew A StrasserDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Mustafa al'AbsiBehavioral Medicine Laboratories, University of Minnesota Medical School, Duluth, Minnesota, United States of America.
Jason D RobinsonDepartment of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Eric C DonnyDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
Dorothy HatsukamiMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Stephen S HechtMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0001-7228-1356
University of Minnesota · USThe University of Texas MD Anderson Cancer Center · USBrown University · USDuke University · USJohns Hopkins University · USUniversity of California, San Francisco · USUniversity of Minnesota, Duluth · USUniversity of Minnesota Medical Center · USUniversity of Pennsylvania · USWake Forest University · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIAU54DA031659 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HATSUKAMI, DOROTHY K · 2011 to 2022
$64.7M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
Stress, Appetite, and Smoking RelapseR01DA027232 · NIDA · UNIVERSITY OF MINNESOTA · PI AL'ABSI, MUSTAFA, LEE, DUSTIN CLARK · 2010 to 2025
$4.6M
Stress Response and Opioid Dysfunction in Nicotine DependenceR01DA016351 · NIDA · UNIVERSITY OF MINNESOTA DULUTH · PI AL'ABSI, MUSTAFA · 2003 to 2023
$4.5M
NCATS NIH HHS UL1 TR002494NCI NIH HHS P30 CA077598NIDA NIH HHS R01 DA016351NIDA NIH HHS R01 DA027232NIDA NIH HHS U54 DA031659
6 · The paper itself

Abstract

The urinary metabolites cyanoethyl mercapturic acid (CEMA) and 3-hydroxypropyl mercapturic acid (3-HPMA) have been widely used as biomarkers of exposure to acrylonitrile and acrolein, respectively, but there are no published data on their consistency over time in the urine of cigarette smokers. We provided, free of charge over a 20 week period, Spectrum NRC600/601 research cigarettes to cigarette smokers in the control arm of a randomized clinical trial of the reduced nicotine cigarette. Urine samples were collected at weeks 4, 8, 12, 16, and 20 and analyzed for CEMA and 3-HPMA, and total nicotine equivalents (TNE) using validated methods. Creatinine-corrected intra-class correlation coefficients for CEMA, 3-HPMA, and TNE were 0.67, 0.46, and 0.68, respectively, indicating good longitudinal consistency for CEMA, while that of 3-HPMA was fair. A strong correlation between CEMA and TNE values was observed. These data support the use of CEMA as a reliable biomarker of tobacco smoke exposure. This is the first report of the longitudinal stability of the biomarkers of acrylonitrile and acrolein exposure in smokers. The data indicate that CEMA, the biomarker of acrylonitrile exposure, is consistent over time in cigarette smokers, supporting its use. While 3-HPMA levels were less stable over time, this biomarker is nevertheless a useful monitor of human acrolein exposure because of its specificity to this toxicant.

Indexed as

AcetylcysteineAcroleinAcrylonitrileAdultBiomarkersCigarette SmokingFemaleHazardous SubstancesHumansLongitudinal StudiesMaleMiddle AgedRandomized Controlled Trials as TopicSmokersTobacco ProductsToxicologyAcetylcysteineAcroleinAcrylonitrileBiomarkersHazardous SubstancesN-acetyl-S-(2-cyanoethyl)cysteineS-(3-hydroxypropyl)cysteine N-acetate

Identifiers

PMID30608961
PMCPMC6319718
OpenAlexW2907793018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.